NCT00227110: Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) |
|
|
| Completed | 4 | 55 | US | Pioglitazone, Actos (Takeda Pharmaceuticals)., Placebo | The University of Texas Health Science Center at San Antonio, National Institutes of Health (NIH), Takeda Pharmaceuticals North America, Inc. | Nonalcoholic Steatohepatitis | 11/05 | 01/06 | | |
NCT04976283: Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver |
|
|
| Recruiting | 4 | 123 | RoW | Pioglitazone, Zolid, Empagliflozin, Diampa, Pioglitazone + Empagliflozin, Zolid + Diampa | Getz Pharma | Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis, NAFLD | 05/23 | 11/23 | | |
